Apollon Wealth Management, LLC Xeris Biopharma Holdings, Inc. Transaction History

Apollon Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$3.95 - $5.16 $161 - $211	41 Added 0.17%	24,201 $113,000
Q1 2025 May 01, 2025	BUY	$3.2 - $5.95 $12,800 - $23,800	4,000 Added 19.84%	24,160 $132,000
Q1 2024 May 02, 2024	SELL	$2.04 - $3.22 $18 - $28	-9 Reduced 0.04%	20,160 $44,000
Q4 2023 Feb 06, 2024	BUY	$1.47 - $2.36 $13 - $21	9 Added 0.04%	20,169 $47,000
Q4 2021 Feb 14, 2022	BUY	$1.8 - $2.93 $36,288 - $59,068	20,160 New	20,160 $59,000

236

94.1M

251K

61.8K

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $986M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Apollon Wealth Management, LLC with notifications on news.